Juncture Wealth Strategies’s Supernus Pharmaceuticals SUPN Stock Holding History

Juncture Wealth Strategies’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$298K	Buy	+6,404	New	+$308K	0.08%	152
2019 Q2	–	Sell	-11,029	Closed	-$386K	–	123
2019 Q1	$386K	Sell	11,029 -4,620	-30%	-$172K	0.3%	88
2018 Q4	$520K	Sell	15,649 -4,225	-21%	-$182K	0.35%	61
2018 Q3	$1M	Sell	19,874 -220	-1%	-$10.9K	0.52%	48
2018 Q2	$1.2M	Sell	20,094 -2,536	-11%	-$131K	0.64%	40
2018 Q1	$1.04M	Sell	22,630 -1,213	-5%	-$50.6K	0.58%	42
2017 Q4	$950K	Sell	23,843 -2,115	-8%	-$83.6K	0.53%	48
2017 Q3	$1.04M	Sell	25,958 -11,015	-30%	-$477K	0.58%	44
2017 Q2	$1.59M	Sell	36,973 -14,486	-28%	-$516K	0.92%	31
2017 Q1	$1.61M	Buy	51,459 +433	+0.8%	+$11.6K	0.99%	31
2016 Q4	$1.29M	Sell	51,026 -7,970	-14%	-$178K	0.89%	30
2016 Q3	$1.46M	Sell	58,996 -1,820	-3%	-$41.2K	0.98%	32
2016 Q2	$1.24M	Sell	60,816 -3,459	-5%	-$61.4K	0.88%	30
2016 Q1	$980K	Buy	64,275 +30,060	+88%	+$392K	0.72%	34
2015 Q4	$460K	Buy	+34,215	New	+$529K	0.34%	62

Other funds holding SUPN

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Ellsworth Advisors Hudson, Ohio $609M AUM 52.37% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

Juncture Wealth Strategies's SUPN Position: Q2 2026 in Review

Juncture Wealth Strategies opened a new position in Supernus Pharmaceuticals (SUPN) in Q2 2026: 6,404 shares worth $298K. The stake represents 0.08% of the portfolio and ranks #152 among its holdings. This is a return to the name: Juncture Wealth Strategies previously reported a position in SUPN as recently as Q1 2019.

Juncture Wealth Strategies first reported a position in SUPN in Q4 2015 and has held it in 15 quarters since. The position peaked at $1.61M in Q1 2017. 27 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

Juncture Wealth Strategies held 6,404 shares of Supernus Pharmaceuticals worth $298K as of Q2 2026.
Supernus Pharmaceuticals was a new Juncture Wealth Strategies position in Q2 2026.
Supernus Pharmaceuticals made up 0.08% of Juncture Wealth Strategies's portfolio in Q2 2026, its #152 holding.
Juncture Wealth Strategies first reported a position in Supernus Pharmaceuticals in Q4 2015 and has held it in 15 quarters since.
Juncture Wealth Strategies's Supernus Pharmaceuticals position peaked at $1.61M in Q1 2017.
27 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on Juncture Wealth Strategies's 13F filing for Q2 2026, filed 9 Jul 2026.